Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $24.9 Million - $33.3 Million
42,003 Added 77.39%
96,275 $74.9 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $3.3 Million - $3.89 Million
6,289 Added 13.11%
54,272 $31.6 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $1.23 Million - $1.69 Million
2,828 Added 6.26%
47,983 $25.8 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $5.73 Million - $7.66 Million
16,329 Added 56.65%
45,155 $21.2 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $42,866 - $50,345
-138 Reduced 0.48%
28,826 $9.9 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $3.23 Million - $3.77 Million
10,052 Added 53.15%
28,964 $10.6 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $641,286 - $730,812
2,163 Added 12.91%
18,912 $6.12 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $509,518 - $598,249
1,828 Added 12.25%
16,749 $5.43 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $183,762 - $228,369
-783 Reduced 4.99%
14,921 $4.27 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $225,749 - $280,156
-1,004 Reduced 6.01%
15,704 $4.34 Million
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $736,155 - $905,942
3,322 Added 24.82%
16,708 $3.86 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $80,164 - $103,691
444 Added 3.43%
13,386 $3.07 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $113,380 - $146,776
-690 Reduced 5.06%
12,942 $2.42 Million
Q4 2020

Feb 17, 2021

BUY
$130.46 - $172.63 $155,508 - $205,774
1,192 Added 9.58%
13,632 $2.3 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $127,065 - $146,973
869 Added 7.51%
12,440 $1.84 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $241,054 - $290,106
-1,767 Reduced 13.25%
11,571 $1.9 Million
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $330,601 - $409,190
2,777 Added 26.29%
13,338 $1.85 Million
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $135,253 - $167,523
-1,265 Reduced 10.7%
10,561 $1.39 Million
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $1,815 - $1,974
-17 Reduced 0.14%
11,826 $1.33 Million
Q2 2019

Aug 12, 2019

BUY
$110.79 - $129.32 $125,525 - $146,519
1,133 Added 10.58%
11,843 $1.31 Million
Q1 2019

May 06, 2019

SELL
$111.31 - $131.02 $117,543 - $138,357
-1,056 Reduced 8.98%
10,710 $1.39 Million
Q4 2018

Feb 15, 2019

SELL
$105.9 - $118.64 $98,169 - $109,979
-927 Reduced 7.3%
11,766 $1.36 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $154,462 - $193,050
1,799 Added 16.51%
12,693 $1.36 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $31,415 - $36,055
-415 Reduced 3.67%
10,894 $934,000
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $15,287 - $18,045
-206 Reduced 1.79%
11,309 $870,000
Q4 2017

Feb 08, 2018

SELL
$81.94 - $87.89 $3,933 - $4,218
-48 Reduced 0.42%
11,515 $973,000
Q3 2017

Nov 16, 2017

SELL
$77.07 - $85.54 $18,728 - $20,786
-243 Reduced 2.06%
11,563 $990,000
Q2 2017

Aug 14, 2017

BUY
N/A
11,806
11,806 $967,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cetera Advisors LLC Portfolio

Follow Cetera Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.